US company COVAXX has announced positive interim data from Phase I clinical trial of its Covid-19 vaccine candidate, UB-612, conducted in Taiwan. UB-612 is a multitope peptide-based vaccine designed to stimulate both B and T-cell arms of the immune system to fight against SARS-CoV-2. It also permits for successful cold chain management with existing infrastructure […]

The biopharma industry has high ambitions to improve therapies for patients across many disease categories, drawing on a wealth of technological advances that have been emerging and maturing in recent years. Even after the mass mobilization against COVID-19, it is clear from the responses of the executives we surveyed that the sector has retained significant […]

As scientific and investment interests in vaccine development advances crescendo on the back of COVID-19, a Cincinnati-based biotech startup seeks to revolutionize the approach to influenza vaccinations.   In the shadows of a global, all-hands-on-deck and historic effort to develop, approve, manufacture, and distribute COVID-19 vaccines, Blue Water Vaccines has been quietly working on a separate […]